Syndicated Research Studies

C-Reactive Protein Testing Market Summary The global C-reactive protein (CRP) testing market was valued at USD 5.27 billion in 2024 and is expected to reach USD 6.08 billion by 2033, registering a CAGR of 1.64% from 2025 to 2033. Market growth is primarily driven by the rising demand for precision medicine and the increasing clinical importance of CRP as an early biomarker of inflammation. CRP is an acute-phase protein that shows elevated levels during the initial stages of disease, making it a critical tool for early diagnosis and disease monitoring. The growing prevalence of chronic conditions such as cardiovascular diseases, diabetes, and autoimmune disorders continues to support market expansion. Additionally, advancements in CRP diagnostic technologies, including improved assay sensitivity, enhanced accuracy, and greater accessibility of testing solutions, are further strengthening market adoption across healthcare settings. The introduction and expansion of point-of-care (POC...

C-reactive Protein Testing  Industry Overview The global C-reactive protein testing market size was valued at USD 5.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 0.3% from 2021 to 2028. Advancements in nanotechnological tools are expected to provide a lucrative perspective in designing portable bioanalytical assays with high specificity and sensitivity, faster response time, and multiplexing capabilities for onsite accurate disease diagnosis and monitoring. Plasmonic Nanoparticles (PNPs) are among the tools that can be used for biosensing applications owing to their versatile optical properties. A study was published in July 2021, in which researchers from Babeș-Bolyai University, Romania provided an overview on plasmonic nanoparticles-based assays for C-reactive protein (CRP) detection. In addition, the study demonstrated the use of newly designed point-of-care assays for rapid CRP testing. Such advancements are anticipated to accelerate ma...